Pricing

Trevi Therapeutics

1 follower

‌

Trevi is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions.

Industries

Biotechnology, Education

Headquarters

New Haven, United States

Employees

11-50

Links

Org chart

Jennifer Good

Co-Founder, President & CEO

Jennifer Good

Collapse

Thomas Sciascia

Co-Founder, Chief Science Officer

Lisa Delfini

CFO

David Clark

Chief Medical Officer

Farrell Simon

Chief Commercial Officer

Katherine Takaki

VP, Global Regulatory Affairs

Katie McManus

Senior Manager, Marketing & Communications

Paula Buckley

VP, Clinical Operations

Pam Nieves

Associate Director, Quality Assurance & Compliance

Teams

Regulatory and Compliance

5 members

Leadership Team

3 members

Medical Affairs and Commercial Strategy

4 members

Clinical Operations

3 members

Finance and Accounting

3 members

Similar companies

Immunome

2 followers

BeiGene

19 followers

University of Richmond

7 followers

Tessera Therapeutics

2 followers

Ventyx Biosciences

1 follower

Pyxis Oncology

1 follower

Mineralys Therapeutics

1 follower

Thrive Capital

26 followers

Podium Education

2 followers

aescape

6 followers

StorONE

6 followers

Explore companies